Corcept Therapeutics (CORT) Non-Current Assets (2010 - 2026)

Corcept Therapeutics (CORT) has 17 years of Non-Current Assets data on file, last reported at $388.8 million in Q1 2026.

• For the quarter ending Q1 2026, Non-Current Assets fell 4.68% year-over-year to $388.8 million; the trailing twelve-month figure through Mar 2026 stood at $1.4 billion (up 10.68% YoY), and the FY2025 full-year result was $351.2 million, down 4.81% from the prior year.
• Non-Current Assets improved to $388.8 million in Q1 2026, from $351.2 million in the prior quarter.
• In the past five years, Non-Current Assets ranged from a high of $408.0 million in Q1 2025 to a low of $77.3 million in Q2 2022.
• A 5-year average of $212.1 million and a median of $162.5 million in 2023 frame the typical range for Non-Current Assets.
• Across the five-year window, Non-Current Assets sank 55.94% in 2022 and soared 167.39% in 2025, its largest moves.
• Tracing CORT's Non-Current Assets over 5 years: stood at $84.2 million in 2022, then surged by 93.5% to $162.9 million in 2023, then soared by 126.52% to $369.0 million in 2024, then decreased by 4.81% to $351.2 million in 2025, then rose by 10.72% to $388.8 million in 2026.
• Business Quant data shows CORT's Non-Current Assets at $388.8 million in Q1 2026, $351.2 million in Q4 2025, and $282.5 million in Q3 2025.